Eidos Therapeutics Company
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Palo Alto, California, United States
Founded Date:
2013
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership